Thus, taken together, preexistence of terminally differentiated, proinflammatory CD8+ and CD4+ subsets compounded with a high-activation-threshold, “reluctant-to-differentiate” CD8+ T cells in DS participants, likely pose immune plasticity challenges. The gene discussed is CD4; the disease is Dravet syndrome.